INHIBRX BIOSCIENCES, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2022 | — | $58.1M | $273.9M |
| Mar 2023 | — | $15.1M | — |
| Jun 2023 | — | $-24.8M | $192.5M |
| Sep 2023 | — | $129.6M | $337.3M |
| Dec 2023 | $207.0M | $43.5M | $277.9M |
| Mar 2024 | — | $11.6M | $252.5M |
| Jun 2024 | $0 | $219.4M | $226.9M |
| Sep 2024 | $0 | $178.5M | $196.3M |
| Dec 2024 | $0 | $133.6M | $152.6M |
| Mar 2025 | $98.7M | $94.4M | $216.5M |
| Jun 2025 | $99.3M | $68.6M | $186.6M |
| Sep 2025 | $99.9M | $36.8M | $153.1M |
| Dec 2025 | $100.6M | $8.0M | $124.2M |
| Mar 2026 | $175.0M | $-21.0M | $161.7M |
| Jun 2026 | $176.3M | $-53.0M | $133.3M |